Skip to main content

Thorne Healthtech, Inc.

THRNDelisted Oct 16, 2023
Industry
Pharmaceutical Preparations
SEC CIK
0001844280

Thorne Healthtech, Inc. was delisted on Oct 16, 2023; its insiders filed their last Form 4 on Oct 18, 2023; 59 institutions reported holding it in 13F filings for Q3 2023, worth $82.9M in total; no superinvestor held it.

Q3 2022 vs. Q2 2022

How the institutions holding Thorne Healthtech, Inc. changed between Q2 2022 and Q3 2022.

All holders in Q3 2022All holders in Q2 2022

13F holders of THRN: Q2 2022 compared with Q3 2022
MeasureQ2 2022Q3 2022Change
Holders4944−5
Shares5.51M5.54M+30.8K (+0.6%)
Value$26.7M$26.2M−$462.0K (−1.7%)

New holders (4)

Institutions that held Thorne Healthtech, Inc. at the end of Q3 2022 but not at the end of Q2 2022.

Institutions new to THRN in Q3 2022
InstitutionSharesValue% of portfolio
Allspring Global Investments Holdings, LLC6,077$28.0K0.00%
BNP Paribas Arbitrage, SA2,905$13.7K0.00%
US Bancorp2,000$9.00K0.00%
Glassman Wealth Services83$00.00%

Sold out (9)

Institutions that held Thorne Healthtech, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.

Institutions that sold out of THRN in Q3 2022
InstitutionShares, Q2 2022Value, Q2 2022
Millennium Management LLC69,450$336.0K
MYDA Advisors LLC69,000$334.0K
Citadel Advisors LLC24,974$121.0K
Jane Street Group, LLC20,701$100.0K
Trexquant Investment LP20,475$99.0K
Acadian Asset Management LLC7,369$36.0K
UBS Group AG1,652$8.00K
The PNC Financial Services Group, Inc.1,000$5.00K
Salem Investment Counselors Inc200$1.00K